Mode
Text Size
Log in / Sign up

Allergy & Immunology

604 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
OTUD1 serves as a potential biomarker for tumor prognosis and cardiovascular disease progression
Allergy & Immunology Sys. Review
OTUD1 serves as a potential biomarker for tumor prognosis and cardiovascular disease progression Protein OTUD1 may help identify tumor stages and risks
This systematic review examines the role of OTUD1-mediated deubiquitination in tumors, cardiovascular diseases, and metabolic conditions. Th…
A protein called OTUD1 acts as a double-edged sword in the body, potentially serving as a key marker for cancer and heart disease progressio…
Chemoradiotherapy combined with immunotherapy improves progression-free and overall survival in limited-stage small-cell lung cancer
Allergy & Immunology Meta-analysis
Chemoradiotherapy combined with immunotherapy improves progression-free and overall survival in limited-stage small-cell lung cancer Immunotherapy Combined With Chemoradiotherapy Shows Promise for Lung Cancer
This meta-analysis of randomized controlled trials evaluated the impact of chemoradiotherapy (CCRT) plus immunotherapy on 1,853 patients wit…
Adding immunotherapy to standard chemoradiotherapy shows a favorable trend in survival for patients with limited-stage small-cell lung cance…
Neural-immune-cardiovascular axis emerges as therapeutic target in atherosclerosis, hypertension, heart failure
Allergy & Immunology Sys. Review
Neural-immune-cardiovascular axis emerges as therapeutic target in atherosclerosis, hypertension, heart failure New pathways link nerves and immunity in heart disease
This systematic review synthesizes evidence on the neural-immune-cardiovascular axis in cardiovascular homeostasis and pathogenesis. It exam…
Scientists are mapping how the connection between your nervous system and immune cells may drive conditions like high blood pressure and hea…
Obinutuzumab achieves 86% overall clinical remission rate in refractory membranous nephropathy
Allergy & Immunology Meta-analysis
Obinutuzumab achieves 86% overall clinical remission rate in refractory membranous nephropathy Obinutuzumab shows promise for patients with hard to treat kidney disease
This meta-analysis evaluates the efficacy and safety of obinutuzumab for patients with refractory membranous nephropathy. The analysis repor…
A new treatment called obinutuzumab shows high remission rates for people with a rare, stubborn kidney condition known as membranous nephrop…
Regulatory and financing barriers primarily hinder optimal care delivery for hereditary angioedema in Balkan countries
Allergy & Immunology Guideline
Regulatory and financing barriers primarily hinder optimal care delivery for hereditary angioedema in Balkan countries Policy gaps create hurdles for patients with hereditary angioedema
This policy and practice review analyzes health systems and care delivery for hereditary angioedema across the Balkan Peninsula. The analysi…
Patients with hereditary angioedema face significant barriers to care, including long wait times for diagnosis and limited access to modern …
FTO-targeted strategies currently lack clinical evaluation and rely on preclinical evidence for cancer treatment
Allergy & Immunology Sys. Review
FTO-targeted strategies currently lack clinical evaluation and rely on preclinical evidence for cancer treatment Targeting the FTO Protein May Improve Cancer Treatment Outcomes in Future Trials
This systematic review examines the role of FTO as a context-dependent epitranscriptomic regulator in cancer. The authors conclude that whil…
Scientists are looking at how targeting a specific protein called FTO could help patients who receive immunotherapy for cancer.
Advanced diagnostic techniques including molecular profiling and AI offer evolving strategies for allergic rhinitis management
Allergy & Immunology Sys. Review
Advanced diagnostic techniques including molecular profiling and AI offer evolving strategies for allergic rhinitis management New Diagnostic Methods Show Progress in Allergic Rhinitis Care
This systematic review examines the evolution of clinical examination techniques for allergic rhinitis from conventional methods to advanced…
Advanced tools like artificial intelligence and molecular testing are evolving how doctors identify and manage allergic rhinitis symptoms.
Omics technologies identify inflammatory, fibrotic, and metabolic programs in secondary lymphedema for target identification
Allergy & Immunology Sys. Review
Omics technologies identify inflammatory, fibrotic, and metabolic programs in secondary lymphedema for target identification New data helps identify biological targets for secondary lymphedema
This systematic review evaluates the role of omics technologies in identifying biomarkers and therapeutic targets for secondary lymphedema. …
Researchers are moving beyond simple physical descriptions of lymphedema to find specific biological markers that could lead to better treat…
Existing food security scales lack the ability to capture unique cultural dimensions for immigrant populations
Allergy & Immunology Sys. Review
Existing food security scales lack the ability to capture unique cultural dimensions for immigrant populations Cultural Food Security Matters for Immigrant and Refugee Communities
This scoping review of 18 studies synthesizes definitions and indicators of cultural food security for immigrants and refugees. The authors …
Standard food security measures often fail to capture the cultural needs of immigrants, highlighting a need for more inclusive community sup…
Integrated biomarker panels provide more complete insights into mechanism-specific therapeutic responses in rheumatoid arthritis
Allergy & Immunology Meta-analysis
Integrated biomarker panels provide more complete insights into mechanism-specific therapeutic responses in rheumatoid arthritis New markers could help predict how rheumatoid arthritis drugs work
This narrative review evaluates conventional and emerging biomarkers for predicting treatment response and resistance in patients with rheum…
Doctors are looking at new biological markers to better predict which treatments will actually work for people with rheumatoid arthritis.
Upstream alarmins IL-33 and TSLP emerge as key targets in T2 asthma pathogenesis
Allergy & Immunology Sys. Review
Upstream alarmins IL-33 and TSLP emerge as key targets in T2 asthma pathogenesis New research identifies key triggers behind Type 2 asthma inflammation
This systematic review synthesizes the complex immune network underlying T2 asthma, highlighting epithelial-derived alarmins IL-33 and TSLP …
Scientists have identified specific early signals that trigger the complex immune response in people with Type 2 asthma.
Zolbetuximab combined with chemotherapy improves progression-free survival and overall survival in CLDN18.2-expressing gastric cancers
Allergy & Immunology Meta-analysis
Zolbetuximab combined with chemotherapy improves progression-free survival and overall survival in CLDN18.2-expressing gastric cancers New drug shows promise for advanced stomach and esophageal cancer
This systematic review evaluates zolbetuximab in combination with chemotherapy for patients with advanced G/GEJ adenocarcinoma expressing hi…
A new treatment called zolbetuximab may improve survival rates for patients with specific types of advanced stomach and esophageal cancers.